NASDAQ:RTIX RTI Surgical Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding RTI Surgical Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $3.14 0.00 (0.00 %) (As of 07/22/2020) Add Compare Share Today's Range$3.12Now: $3.14▼$3.3050-Day Range$3.14MA: $3.14▼$3.1452-Week Range$1.46Now: $3.14▼$5.40Volume686,036 shsAverage Volume622,541 shsMarket Capitalization$234.25 millionP/E RatioN/ADividend YieldN/ABeta2.14 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media RTI Surgical Holdings, Inc., a surgical implant company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes. The company's implants are used in the fields of orthopedic, spine, sports medicine, general surgery, trauma and other surgical procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force, as well as through a network of independent distributors. RTI Surgical Holdings, Inc. was founded in 1997 and is based in Deerfield, Illinois.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingRTI Surgical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $5.00, RTI Surgical has a forecasted upside of 59.2% from its current price of $3.14.Amount of Analyst CoverageRTI Surgical has received no research coverage in the past 90 days. Previous Next 2.2 Community Rank Outperform VotesRTI Surgical has received 337 “outperform” votes. (Add your “outperform” vote.)Underperform VotesRTI Surgical has received 415 “underperform” votes. (Add your “underperform” vote.)Community SentimentRTI Surgical has received 55.19% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about RTI Surgical and other stocks. Vote “Outperform” if you believe RTIX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RTIX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldRTI Surgical does not currently pay a dividend.Dividend GrowthRTI Surgical does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, RTI Surgical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.70% of the stock of RTI Surgical is held by insiders.Percentage Held by Institutions60.97% of the stock of RTI Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for RTI Surgical are expected to grow in the coming year, from ($0.30) to ($0.03) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of RTI Surgical is -1.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of RTI Surgical is -1.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRTI Surgical has a P/B Ratio of 1.09. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.47 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical appliances & supplies Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNASDAQ:RTIX Previous Symbol CUSIP74975N10 CIK1100441 Webwww.rtix.com Phone386-418-8888Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$308.38 million Price / Sales0.76 Cash Flow$0.30 per share Price / Cash Flow10.31 Book Value$2.89 per share Price / Book1.09Profitability EPS (Most Recent Fiscal Year)($0.16) Net Income$-211,640,000.00 Net Margins-70.56% Return on EquityN/A Return on AssetsN/AMiscellaneous Employees891 Outstanding Shares74,601,000Market Cap$234.25 million Next Earnings Date9/30/2020 (Estimated) OptionableOptionable $3.14 0.00 (0.00 %) (As of 07/22/2020) 30 days | 90 days | 365 days | Advanced Chart Receive RTIX News and Ratings via Email Sign-up to receive the latest news and ratings for RTIX and its competitors with MarketBeat's FREE daily newsletter. RTI Surgical (NASDAQ:RTIX) Frequently Asked Questions How has RTI Surgical's stock been impacted by COVID-19 (Coronavirus)? RTI Surgical's stock was trading at $3.09 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, RTIX stock has increased by 1.6% and is now trading at $3.14. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of RTI Surgical? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RTI Surgical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for RTI Surgical. When is RTI Surgical's next earnings date? RTI Surgical is scheduled to release its next quarterly earnings announcement on Wednesday, September 30th 2020. View our earnings forecast for RTI Surgical. How were RTI Surgical's earnings last quarter? RTI Surgical Holdings Inc (NASDAQ:RTIX) posted its quarterly earnings results on Tuesday, June, 30th. The medical equipment provider reported ($0.03) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.01 by $0.04. The medical equipment provider earned $73.73 million during the quarter. View RTI Surgical's earnings history. What price target have analysts set for RTIX? 1 equities research analysts have issued 1 year target prices for RTI Surgical's stock. Their forecasts range from $5.00 to $5.00. On average, they anticipate RTI Surgical's stock price to reach $5.00 in the next year. This suggests a possible upside of 59.2% from the stock's current price. View analysts' price targets for RTI Surgical. Who are some of RTI Surgical's key competitors? Some companies that are related to RTI Surgical include Align Technology (ALGN), West Pharmaceutical Services (WST), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Quidel (QDEL), Haemonetics (HAE), Neogen (NEOG), ICU Medical (ICUI), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Atrion (ATRI), Cerus (CERS), OraSure Technologies (OSUR), Meridian Bioscience (VIVO) and Anika Therapeutics (ANIK). View all competitors. What other stocks do shareholders of RTI Surgical own? Based on aggregate information from My MarketBeat watchlists, some companies that other RTI Surgical investors own include LightPath Technologies (LPTH), Exfo (EXFO), TherapeuticsMD (TXMD), Merit Medical Systems (MMSI), Advanced Micro Devices (AMD), Rigel Pharmaceuticals (RIGL), CorMedix (CRMD), Pfizer (PFE), Sorrento Therapeutics (SRNE) and Biocept (BIOC). Who are RTI Surgical's key executives? RTI Surgical's management team includes the following people: Mr. Camille I. Farhat, CEO, Pres & Director (Age 49)Mr. Jonathon M. Singer, Chief Financial & Admin. Officer and Corp. Sec. (Age 55)Mr. John N. Varela, Exec. VP of Global Operations (Age 52)Mr. Tony Lemus, VP of Global R&D, Clinical and RegulatoryMs. Molly Poarch, Director of Corp. Communications What is RTI Surgical's stock symbol? RTI Surgical trades on the NASDAQ under the ticker symbol "RTIX." Who are RTI Surgical's major shareholders? RTI Surgical's stock is owned by a number of institutional and retail investors. Top institutional investors include Krensavage Asset Management LLC (7.84%), Paradigm Capital Management Inc. NY (6.57%), Wasatch Advisors Inc. (1.78%), Gabelli Funds LLC (0.46%), Nuveen Asset Management LLC (0.39%) and Grantham Mayo Van Otterloo & Co. LLC (0.35%). Company insiders that own RTI Surgical stock include Camille Farhat and Jonathon M Singer. View institutional ownership trends for RTI Surgical. Which major investors are selling RTI Surgical stock? RTIX stock was sold by a variety of institutional investors in the last quarter, including Paradigm Capital Management Inc. NY, UBS Group AG, and Teton Advisors Inc.. View insider buying and selling activity for RTI Surgical. Which major investors are buying RTI Surgical stock? RTIX stock was bought by a variety of institutional investors in the last quarter, including Krensavage Asset Management LLC, Wasatch Advisors Inc., Goldman Sachs Group Inc., Grantham Mayo Van Otterloo & Co. LLC, Yakira Capital Management Inc., Dfpg Investments LLC, Assenagon Asset Management S.A., and Dupont Capital Management Corp. Company insiders that have bought RTI Surgical stock in the last two years include Camille Farhat, and Jonathon M Singer. View insider buying and selling activity for RTI Surgical. How do I buy shares of RTI Surgical? Shares of RTIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is RTI Surgical's stock price today? One share of RTIX stock can currently be purchased for approximately $3.14. How big of a company is RTI Surgical? RTI Surgical has a market capitalization of $234.25 million and generates $308.38 million in revenue each year. The medical equipment provider earns $-211,640,000.00 in net income (profit) each year or ($0.16) on an earnings per share basis. RTI Surgical employs 891 workers across the globe. What is RTI Surgical's official website? The official website for RTI Surgical is www.rtix.com. How can I contact RTI Surgical? RTI Surgical's mailing address is 11621 RESEARCH CIRCLE, ALACHUA FL, 32615. The medical equipment provider can be reached via phone at 386-418-8888 or via email at [email protected] This page was last updated on 9/28/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
